首页> 外文会议>International symposium on crystal engineering and drug delivery system >Preparation of stable nitrendipine nanocystal suspension using a modified anti-solvent precipitation method
【24h】

Preparation of stable nitrendipine nanocystal suspension using a modified anti-solvent precipitation method

机译:使用改性抗溶剂沉淀法制备稳定的硝酸齐屈氏型纳米囊悬浮液

获取原文

摘要

Objects: The aim of this study was to investigate the effect of stabilizer and crystal size on the nanosuspension stability, dissolution rate and solubility of water insoluble drug. Nitrendipine was used as a poor water soluble model drug. Methods: Nanocrystal suspensions of nitrendipine were produced by modified anti-solvent precipitation method. Firstly, nitrendipine was dissolved in the mixed solvent of PEG200 and acetone to form an organic solution. Then, the drug solution was quickly injected into water phase under a magnetic stirring and the ultrasonication was performed to produce dispersed drug crystals. To prevent the crystals growing up, some stabilizer was introduced in water phase and the effect of kind of stabilizer and concentration on the crystal size was investigated. As well as the drug concentration in organic phase, time of ultrasonication and temperature on the particle size and stability were investigated. The particle size, Zeta potential and morphology of nanocrystals were characterized by the laser diffractometry, Zeta potential analyzer and scanning electron microscope (SEM), respectively. X-ray powder diffraction (XRPD) and differential scanning calorimetry (DSC) were used to analyze the crystalline change of nanocrystals. Dissolution experiments of nitrendipine nanosuspension and raw crystals were performed according to Ch.P.2005 Ed Apparatus III (paddle) method. The solubility of nanocrystals with different mean particle size was determined by HPLC method.Results and discussions: It was well known that the crystal size was largely affected by various operating condition during precipitation process. It was found that the stabilizer should be introduced in water phase to prevent crystal growth and to be advantageous to form crystal nucleus. Some materials were introduced into water phase to control the crystal size. Among them, PVA was selected as a good stabilizer and efficiently arrested crystal growth. Following precipitation, ultrasonic treatment remarkably enhanced stability of nitrendipine nanosuspension. The influences on the crystal size of nitrendipine were investigated systematically. In this modified anti-solvent precipitation, the mean particle size could be well controlled, from 137nm to 2.86μm by adjusting the operation parameters, such as the drug content and PVA concentration. Higher concentration of nitrendipine in organic phase, higher concentration of PVA was required to achieve smaller particle size. In addition, particle size decreased with the increase of ultrasonic power. The process time of ultrasonication also had an effect on the particle size. The mean particle size was decreased with increasing time of ultrasonication within 15min. However, nanosuspension was not stable when the ultrasonication was applied for 5 min. The temperature of precipitation also affected the average particle size, the lower the temperature, the smaller the crystals. The morphology of crystals under ultrasonic treatment was diverse. With SEM photo observation, plate-like crystals with different shape were obtained after ultrasonication (see Fig.1). X-ray powder diffraction confirmed that no crystalline change was found in the various crystals produced in different condition. However, the differences in the relative intensities of their peaks might be attributed to the differences in crystallinity. All DSC scans of each sample were showed a single sharp endothermic peak ascribing melting of nitrendipine, which also indicated that no substantially crystalline change was found. However, the melting point of crystals obtained with and without ultrasonic treatment was lower than that of original crystals, this might be explained by the size reduction of crystals. The dissolution profiles of nanosized and raw nitrendipine crystals are shown in Fig.2-a. When water containing 0.1mol/L hydrochloric acid and 0.1% SDS was used as dissolution medium, the original crystals did not achieve complete dissolution d
机译:对象:本研究的目的是探讨稳定剂和晶体尺寸对纳米柱稳定性,溶出速率和水不溶性药物溶解度的影响。 Nitrendipine被用作可怜的水溶性模型药物。方法:通过改性的抗溶剂沉淀法生产纳米替纳脂素的纳米晶悬浮液。首先,将硝酸化平滑笔溶于PEG200的混合溶剂和丙酮中以形成有机溶液。然后,在磁搅拌下将药物溶液迅速喷射到水相中,进行超声波以产生分散的药物晶体。为了防止生长的晶体,在水相中引入了一些稳定剂,研究了稳定剂和浓度对晶体尺寸的效果。除了有机相中的药物浓度,还研究了超声波和粒度的温度和稳定性的温度。纳米晶体的粒度,Zeta电位和形态分别是激光衍射测定,Zeta电位分析仪和扫描电子显微镜(SEM)。 X射线粉末衍射(XRPD)和差示扫描量热法(DSC)用于分析纳米晶体的晶体变化。根据CH.P.2005 ED装置III(桨)方法进行硝化培训线纳米山缺失和原晶的溶出实验。通过HPLC方法测定纳米晶体具有不同平均粒度的溶解度。结果和讨论:众所周知,沉淀过程中晶体尺寸主要受各种操作条件的影响。发现稳定剂应在水相中引入以防止晶体生长并具有有利的形成晶体。将一些材料引入水相以控制晶体尺寸。其中,选择PVA作为良好的稳定剂,有效地阻止晶体生长。沉淀后,超声波处理显着提高了硝化平纳米柱的稳定性。系统地研究了对Nitrendipine的晶体尺寸的影响。在该改性的抗溶剂沉淀中,通过调节操作参数,例如药物含量和PVA浓度,平均粒度可以很好地控制,从137nm到2.86μm。在有机相中较高浓度的硝酸齐屈,需要较高浓度的PVA来实现更小的粒度。此外,随着超声波功率的增加,粒度降低。超声处理的过程时间也对粒度产生了影响。随着15min内的超声升高而降低平均粒度。然而,当施加超声施用5分钟时,纳米孔术不稳定。沉淀温度也影响了平均粒径,温度越低,晶体越小。超声处理下晶体的形态多样化。通过SEM拍照观察,超声处理后获得具有不同形状的板状晶体(见图1)。 X射线粉末衍射证实,在不同条件下产生的各种晶体中没有发现结晶变化。然而,其峰的相对强度的差异可能归因于结晶度的差异。每种样品的所有DSC扫描都显示出嵌入硝化平的熔化的单一尖锐的吸热峰,这也表明未发现基本上结晶的变化。然而,使用和不具有超声处理的晶体的熔点低于原始晶体的熔点,这可能通过晶体的尺寸减少来解释。纳米化和未硝酸亚硫曲线晶体的溶解曲线如图2-a所示。当含有0.1mol / L盐酸和0.1%SDS的水作为溶解介质时,原始晶体未达到完全溶解D.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号